Jpmorgan Chase & CO Xencor Inc Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Xencor Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 126,719 shares of XNCR stock, worth $2.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

126,719

Previous 129,211 1.93%

Holding current value

$2.73 Million

Previous $2.86 Million 16.12%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$18.21 - $24.5 $45,379 - $61,054	-2,492 Reduced 1.93%	126,719 $2.4 Million
Q1 2024 May 10, 2024	SELL	$18.65 - $26.52 $6.94 Million - $9.86 Million	-371,956 Reduced 74.22%	129,211 $2.86 Million
Q4 2023 Feb 12, 2024	SELL	$16.53 - $21.42 $56,483 - $73,192	-3,417 Reduced 0.68%	501,167 $10.6 Million
Q3 2023 Nov 14, 2023	SELL	$20.08 - $25.39 $464,349 - $587,143	-23,125 Reduced 4.38%	504,584 $10.2 Million
Q2 2023 Aug 11, 2023	BUY	$24.77 - $29.9 $1.26 Million - $1.53 Million	51,042 Added 10.71%	527,709 $13.2 Million
Q1 2023 May 18, 2023	BUY	$25.95 - $36.95 $1.9 Million - $2.71 Million	73,325 Added 18.18%	476,667 $13.3 Million
Q1 2023 May 11, 2023	SELL	$25.95 - $36.95 $1.78 Million - $2.54 Million	-68,760 Reduced 14.56%	403,342 $11.2 Million
Q4 2022 Feb 13, 2023	SELL	$24.79 - $30.86 $566,377 - $705,058	-22,847 Reduced 4.62%	472,102 $12.3 Million
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $292,731 - $385,711	-11,890 Reduced 2.35%	494,949 $12.9 Million
Q2 2022 Aug 11, 2022	SELL	$19.74 - $29.01 $54,778 - $80,502	-2,775 Reduced 0.54%	506,839 $13.9 Million
Q1 2022 May 11, 2022	SELL	$26.68 - $41.63 $223,791 - $349,192	-8,388 Reduced 1.62%	509,614 $13.6 Million
Q4 2021 Feb 10, 2022	SELL	$33.67 - $43.44 $357,676 - $461,463	-10,623 Reduced 2.01%	518,002 $20.8 Million
Q3 2021 Nov 12, 2021	BUY	$30.65 - $35.68 $16.2 Million - $18.9 Million	528,625 New	528,625 $17.3 Million

Others Institutions Holding XNCR

# of Institutions

203

Shares Held

63.2M

Call Options Held

3.9K

Put Options Held

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.28B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Xencor Inc Transaction History